Goldman Sachs
GDRX icon

Goldman Sachs’s GoodRx Holdings GDRX Stock Holding History

Goldman Sachs’s Portfolio GDRX Stock Details GDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-122,400
Closed -$332K – 6685
2025
Q4 		$332K Buy
+122,400
New +$402K ﹤0.01% 5814

Other funds holding GDRX

FPM
Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SLG
Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PTC
Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return

Goldman Sachs's GDRX Position: Q1 2026 in Review

Goldman Sachs reduced its GoodRx Holdings (GDRX) stake by 33% in Q1 2026, selling an estimated $1.22M and leaving 1,057,961 shares worth $2.07M. The position accounts for ﹤0.01% of the portfolio, ranked #4516.

Goldman Sachs first reported a position in GDRX in Q3 2020 and has held it in 23 quarters since. The position peaked at $101M in Q2 2021. 174 funds tracked by Wall St. Rank hold GDRX as of Q1 2026.

  • Goldman Sachs held 1,057,961 shares of GoodRx Holdings worth $2.07M as of Q1 2026.
  • Goldman Sachs sold 521,313 GoodRx Holdings shares in Q1 2026, an estimated $1.22M.
  • GoodRx Holdings made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #4516 holding.
  • Goldman Sachs first reported a position in GoodRx Holdings in Q3 2020 and has held it in 23 quarters since.
  • Goldman Sachs's GoodRx Holdings position peaked at $101M in Q2 2021.
  • 174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.